Jim Simons Bluejay Diagnostics, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.19 - $0.41 $2,394 - $5,166	12,600 Added 34.52%	49,100 $13,000
Q1 2023 May 12, 2023	SELL	$0.38 - $0.87 $11,130 - $25,483	-29,291 Reduced 44.52%	36,500 $15,000
Q4 2022 Feb 13, 2023	BUY	$0.34 - $138.99 $5,504 - $2.25 Million	16,191 Added 32.64%	65,791 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.83 - $132.53 $747 - $119,409	-901 Reduced 1.78%	49,600 $39,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.63 $47,470 - $82,316	50,501 New	50,501 $54,000

Ticker BJDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,152,300
Market Cap $3.63M
Description
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.